Advertisement
Screener

TVARDI THERAPEUTICS, INC. (TVRD) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

TVARDI THERAPEUTICS, INC. Stock-Based Compensation

TVARDI THERAPEUTICS, INC. (TVRD) reported Stock-Based Compensation of $705.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-14

  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $335.00K, a 46.57% decline year-over-year.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $370.00K, a 362.50% increase year-over-year.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $353.00K, a 346.84% increase year-over-year.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $339.00K, a 323.75% increase year-over-year.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.40M, a 338.56% increase from fiscal 2024.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $319.00K, a 97.68% decline from fiscal 2023.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $13.73M, a 22.58% decline from fiscal 2022.
  • TVARDI THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $17.73M, a 14.68% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$335.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$705.00K
10-Q · filed 2026-08-14
$1.06M
derived: sum of 3 quarters · filed 2026-08-14
$1.40M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$370.00K
10-Q · filed 2026-05-08
$723.00K
derived: sum of 2 quarters · filed 2026-05-08
$1.06M
derived: sum of 3 quarters · filed 2026-05-08
$1.69M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$353.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$692.00K
derived: sum of 2 quarters · filed 2026-03-31
$1.32M
derived: sum of 3 quarters · filed 2026-08-14
$1.40M
10-K · filed 2026-03-31
2025-09-30$339.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$966.00K
derived: sum of 2 quarters · filed 2026-08-14
$1.05M
10-Q · filed 2025-11-13
$1.13M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$627.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$707.00K
10-Q · filed 2026-08-14
$786.00K
derived: sum of 3 quarters · filed 2026-08-14
$866.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$80.00K
10-Q · filed 2026-05-08
$1.43M
10-Q · filed 2025-05-13
$159.00K
derived: sum of 2 quarters · filed 2026-05-08
$239.00K
derived: sum of 3 quarters · filed 2026-05-08
-$2.95M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$79.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$159.00K
derived: sum of 2 quarters · filed 2026-03-31
-$3.03M
derived: sum of 3 quarters · filed 2026-03-31
$319.00K
10-K · filed 2026-03-31
$8.93M
10-K · filed 2025-03-11
2024-09-30$80.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$3.10M
derived: sum of 2 quarters · filed 2025-11-13
$240.00K
10-Q · filed 2025-11-13
$6.58M
10-Q · filed 2024-11-14
$3.84M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$3.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$160.00K
10-Q · filed 2025-08-14
$5.09M
10-Q · filed 2024-08-14
$3.76M
derived: sum of 3 quarters · filed 2025-08-14
$7.09M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$3.35M
10-Q · filed 2025-05-13
$6.95M
derived: sum of 2 quarters · filed 2025-05-13
$10.28M
derived: sum of 3 quarters · filed 2025-05-13
$13.72M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$3.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$6.93M
derived: sum of 2 quarters · filed 2025-03-11
$10.38M
derived: sum of 3 quarters · filed 2025-03-11
$13.73M
10-K · filed 2025-03-11
2023-09-30$3.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$6.78M
derived: sum of 2 quarters · filed 2024-11-14
$10.13M
10-Q · filed 2024-11-14
$13.93M
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$6.79M
10-Q · filed 2024-08-14
$10.60M
derived: sum of 3 quarters · filed 2025-03-11
$14.17M
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31$3.35M
10-Q · filed 2024-05-13
$7.15M
derived: sum of 2 quarters · filed 2025-03-11
$10.73M
derived: sum of 3 quarters · filed 2025-03-11
$15.38M
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31$3.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$7.38M
derived: sum of 2 quarters · filed 2025-03-11
$12.03M
derived: sum of 3 quarters · filed 2025-03-11
$17.73M
10-K · filed 2025-03-11
2022-09-30$3.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$8.23M
derived: sum of 2 quarters · filed 2023-11-13
$13.93M
10-Q · filed 2023-11-13
$22.72M
derived: sum of 4 quarters · filed 2024-03-06
2022-06-30$4.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$10.36M
10-Q · filed 2023-08-07
$19.14M
derived: sum of 3 quarters · filed 2024-03-06
$23.54M
derived: sum of 4 quarters · filed 2024-03-06
2022-03-31$5.70M
10-Q · filed 2023-05-15
$14.49M
derived: sum of 2 quarters · filed 2024-03-06
$18.88M
derived: sum of 3 quarters · filed 2024-03-06
$22.36M
derived: sum of 4 quarters · filed 2024-03-06
2021-12-31$8.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
$13.18M
derived: sum of 2 quarters · filed 2024-03-06
$16.65M
derived: sum of 3 quarters · filed 2024-03-06
$20.79M
10-K · filed 2024-03-06
2021-09-30$4.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$7.87M
derived: sum of 2 quarters · filed 2022-11-07
$12.00M
10-Q · filed 2022-11-07
$16.07M
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30$3.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$7.61M
10-Q · filed 2022-08-08
$11.67M
derived: sum of 3 quarters · filed 2023-03-06
$14.98M
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31$4.13M
10-Q · filed 2022-05-09
$8.20M
derived: sum of 2 quarters · filed 2023-03-06
$11.50M
derived: sum of 3 quarters · filed 2023-03-06
$16.12M
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31$4.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$7.37M
derived: sum of 2 quarters · filed 2023-03-06
$11.99M
derived: sum of 3 quarters · filed 2023-03-06
$14.84M
10-K · filed 2023-03-06
2020-09-30$3.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$7.92M
derived: sum of 2 quarters · filed 2021-11-08
$10.77M
10-Q · filed 2021-11-08
$14.16M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$4.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$7.46M
10-Q · filed 2021-08-09
$10.85M
derived: sum of 3 quarters · filed 2022-03-01
$13.78M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$2.85M
10-Q · filed 2021-05-10
$6.23M
derived: sum of 2 quarters · filed 2022-03-01
$9.16M
derived: sum of 3 quarters · filed 2022-03-01
$13.18M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$3.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$6.32M
derived: sum of 2 quarters · filed 2022-03-01
$10.33M
derived: sum of 3 quarters · filed 2022-03-01
$12.57M
10-K · filed 2022-03-01
2019-09-30$2.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$6.95M
derived: sum of 2 quarters · filed 2020-11-09
$9.18M
10-Q · filed 2020-11-09
$12.90M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$4.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$6.25M
10-Q · filed 2020-08-10
$9.97M
derived: sum of 3 quarters · filed 2021-02-25
$11.79M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$2.23M
10-Q · filed 2020-05-11
$5.95M
derived: sum of 2 quarters · filed 2021-02-25
$7.77M
derived: sum of 3 quarters · filed 2021-02-25
$9.84M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$3.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$5.54M
derived: sum of 2 quarters · filed 2021-02-25
$7.61M
derived: sum of 3 quarters · filed 2021-02-25
$9.48M
10-K · filed 2021-02-25
2018-09-30$1.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$3.89M
derived: sum of 2 quarters · filed 2019-11-05
$5.76M
10-Q · filed 2019-11-05
$7.51M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$2.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$3.94M
10-Q · filed 2019-08-07
$5.69M
derived: sum of 3 quarters · filed 2020-02-27
$7.31M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$1.87M
10-Q · filed 2019-05-07
$3.62M
derived: sum of 2 quarters · filed 2020-02-27
$5.24M
derived: sum of 3 quarters · filed 2020-02-27
$6.56M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$3.37M
derived: sum of 2 quarters · filed 2020-02-27
$4.68M
derived: sum of 3 quarters · filed 2020-02-27
$5.79M
10-K · filed 2020-02-27
2017-09-30$1.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$2.94M
derived: sum of 2 quarters · filed 2018-11-06
$4.05M
10-Q · filed 2018-11-06
$4.88M
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30$1.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$2.43M
10-Q · filed 2018-08-07
$3.25M
derived: sum of 3 quarters · filed 2019-03-12
$4.03M
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31$1.11M
10-Q · filed 2018-05-09
$1.94M
derived: sum of 2 quarters · filed 2019-03-12
$2.71M
derived: sum of 3 quarters · filed 2019-03-12
$3.41M
derived: sum of 4 quarters · filed 2019-03-12
2016-12-31$829.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$1.61M
derived: sum of 2 quarters · filed 2019-03-12
$2.30M
derived: sum of 3 quarters · filed 2019-03-12
$2.80M
10-K · filed 2019-03-12
2016-09-30$777.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$1.48M
derived: sum of 2 quarters · filed 2017-11-02
$1.97M
10-Q · filed 2017-11-02
$2.68M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$698.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.19M
10-Q · filed 2017-08-03
$1.90M
derived: sum of 3 quarters · filed 2018-03-15
$2.56M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$496.00K
10-Q · filed 2017-05-04
$1.20M
derived: sum of 2 quarters · filed 2018-03-15
$1.86M
derived: sum of 3 quarters · filed 2018-03-15
$2.56M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$707.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$1.37M
derived: sum of 2 quarters · filed 2018-03-15
$2.07M
derived: sum of 3 quarters · filed 2018-03-15
$2.51M
10-K · filed 2018-03-15
2015-09-30$661.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$1.36M
derived: sum of 2 quarters · filed 2016-11-04
$1.81M
10-Q · filed 2016-11-04
$2.15M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$701.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$1.15M
10-Q · filed 2016-08-04
$1.49M
derived: sum of 3 quarters · filed 2017-03-10
$1.71M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$445.00K
10-Q · filed 2016-05-05
$785.00K
derived: sum of 2 quarters · filed 2017-03-10
$1.01M
derived: sum of 3 quarters · filed 2017-03-10
$1.46M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$340.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$562.00K
derived: sum of 2 quarters · filed 2017-03-10
$1.02M
derived: sum of 3 quarters · filed 2017-03-10
$1.37M
10-K · filed 2017-03-10
2014-09-30$222.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$678.00K
derived: sum of 2 quarters · filed 2015-11-09
$1.03M
10-Q · filed 2015-11-09
$1.04M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$456.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$809.00K
10-Q · filed 2015-08-10
$822.00K
derived: sum of 3 quarters · filed 2016-03-11
$881.00K
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$353.00K
10-Q · filed 2015-05-12
-$353.00K
10-Q · filed 2014-05-12
$366.00K
derived: sum of 2 quarters · filed 2016-03-11
$425.00K
derived: sum of 3 quarters · filed 2016-03-11
$487.00K
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$72.00K
derived: sum of 2 quarters · filed 2016-03-11
$134.00K
derived: sum of 3 quarters · filed 2016-03-11
$123.00K
10-K · filed 2016-03-11
2013-09-30$59.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$121.00K
derived: sum of 2 quarters · filed 2014-11-10
$110.00K
10-Q · filed 2014-11-10
2013-06-30$62.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$51.00K
10-Q · filed 2014-08-07
2013-03-31-$11.00K
10-Q · filed 2014-05-12
2012-12-31$61.00K
10-K · filed 2015-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36